Topiramate is known to occasionally cause a condition called metabolic acidosis
Our physicians design customized treatment schedules that may range from single courses to periodic interventions with comprehensive monitoring throughout
Summary: GLP-1 receptor agonists are not licensed for NAFLD treatment in the UK but may reduce liver fat and improve metabolic parameters when prescribed for type 2 diabetes or weight management in eligible patients with concurrent liver disease
ATP-based luminescence assays, such as the CellTiter-Glo 2.0 Assay, are the preferred platform for HTS drug screening because they offer the highest sensitivity (detecting 15100 cells/well), the simplest protocol (single reagent addition, 10-minute read time), and the lowest coefficient of variation across plate formats
It is often used as an initial or maintenance dose in aesthetic and medical treatments
Boosting fat burning with carnitine: an old friend comes out from the shadow 8